PMID: 9427890Jan 15, 1998Paper

Acceptability and impact of zidovudine for prevention of mother-to-child human immunodeficiency virus-1 transmission in France

The Journal of Pediatrics
M J MayauxS Blanche

Abstract

We studied the propagation and the impact of zidovudine prevention on the human immunodeficiency virus-1 transmission rate from infected mothers to their infants in the French nationwide prospective cohort. Infection was diagnosed in the children on the basis of at least two positive human immunodeficiency virus-1 polymerase chain reaction tests, culture, or both. The transmission rate among treated women was compared with that among untreated women during the same period and with that among women enrolled in the cohort since 1986. The impact of zidovudine was analyzed according to the women's clinical and biologic characteristics, the mode of delivery, and use of zidovudine therapy before the pregnancy. Nearly 90% of women were treated as soon as the second half of 1994. In 1994 and 1995, 80% of mother-child pairs received at least one of the three phases of preventive treatment. Among the 663 mothers enrolled during these 2 years, only six refused the treatment. Zidovudine treatment was associated with a reduction in the transmission rate of nearly two-thirds, from 14% +/- 6% to 5% +/- 2% (p < 0.01). The degree of reduction was not influenced by the maternal CD4+ cell count or p24 antigenemia at delivery. Zidovudine treatment...Continue Reading

References

May 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L M FrenkelR C Reichman
Jun 22, 1994·JAMA : the Journal of the American Medical Association·P J BoyerY J Bryson
Jun 20, 1996·The New England Journal of Medicine·D V Landers, R L Sweet

❮ Previous
Next ❯

Citations

Jul 13, 2006·Maternal and Child Health Journal·Margaret A Lampe
Sep 11, 2002·European Journal of Obstetrics, Gynecology, and Reproductive Biology·A BongainJ Y Gillet
Apr 28, 2000·Early Human Development·C Thorne, M L Newell
Jan 6, 2001·Infectious Disease Clinics of North America·N A Kartsonis, R T D'Aquila
Apr 3, 1999·The New England Journal of Medicine·S A FiscusC Wilfert
Jun 5, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Y SitnitskayaW Borkowsky
Aug 17, 1999·Sexually Transmitted Infections·G P TaylorG Tudor-Williams
Sep 22, 2009·Retrovirology·Constance DelaugerreUNKNOWN ANRS French Perinatal Cohort
Jul 18, 2000·American Journal of Public Health·N Kass
Jul 8, 2010·Indian Journal of Community Medicine : Official Publication of Indian Association of Preventive & Social Medicine·Kanchan Mukherjee
Mar 4, 2000·Pediatric Clinics of North America·M G FowlerA Roongpisuthipong
Nov 7, 2008·American Journal of Obstetrics and Gynecology·Laurent MandelbrotUNKNOWN ANRS French Perinatal Cohort (EPF)
Mar 4, 2000·Pediatric Clinics of North America·M Bulterys, M G Fowler
Mar 6, 2008·Anesthesiology Clinics·Rachel Hignett, Roshan Fernando
Aug 23, 2000·Hospital Medicine·L GreenJ Catalan
Jul 13, 2004·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Nancy A WadeGuthrie S Birkhead
Mar 9, 2007·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Claire Thorne, Marie-Louise Newell
Apr 26, 2007·AIDS·Claudia Palladino Sili ScavalliUNKNOWN ANRS EPF
Aug 28, 2001·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·G P Taylor, N Low-Beer
Nov 15, 2003·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Denise J JamiesonStefan Z Wiktor
May 4, 1999·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·I C HansonD E Shapiro
Jun 19, 2001·Journal of Acquired Immune Deficiency Syndromes : JAIDS·B MasquelierUNKNOWN French Pediatric HIV Infection Study Group
May 1, 2002·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Ellen R CooperUNKNOWN Women and Infants' Transmission Study Group
Apr 29, 1998·Current Opinion in Obstetrics & Gynecology·L Mandelbrot

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Acta Paediatrica. Supplement
M Fowler, L M Mofenson
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
J Poulton
Nature Biotechnology
R Peters, R S Sikorski
International Journal of Health Care Quality Assurance Incorporating Leadership in Health Services
N Bosanquet
© 2021 Meta ULC. All rights reserved